Chester County News and Community Website
KING OF PRUSSIA, PA — XyloCor Therapeutics Inc. announced the appointment of John Tucker as president and chief executive officer, effective immediately.
XyloCor Therapeutics Appoints John Tucker President and CEO Read More KING OF PRUSSIA, PA — XyloCor Therapeutics has dosed the first patient in its Phase 2b EXACT-2 trial evaluating XC001 (encoberminogene rezmadenovec), a novel gene therapy designed to help patients …
XyloCor Doses First Patient in Pivotal Gene Therapy Trial for Refractory Angina Read More WAYNE, PA, and TULLINGE, Sweden — XyloCor Therapeutics, Inc. recently secured licensing rights to the Extroducer® Infusion Catheter System from SmartWise. This innovative device is set to revolutionize the delivery …
XyloCor Therapeutics and SmartWise Team Up to Enhance Gene Therapy Delivery Read More WAYNE, PA, and TULLINGE, Sweden — XyloCor Therapeutics, Inc. has signed a licensing agreement with SmartWise to use the Extroducer Infusion Catheter System. This endovascular device is designed to deliver …
XyloCor Therapeutics Licenses SmartWise Device for Advanced Heart Therapy Delivery Read More